Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

The C-terminal tail of AHF/trichohyalin is essential for organizing keratin filaments in keratinocytes.

N-acetyl-cysteine improves hair growth and is safe for treating early male hair loss.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

Energy healing treatment improved L-cysteine's stability, solubility, bioavailability, and shelf-life.

Ion sequential therapy improves heart function after a heart attack.

Neuronatin is found in various cells of rat tissues and has a unique location in sperm cells.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

The research found enzymes in Stephania epigaea that help make cepharanthine.

Stem cells improve nerve repair by enhancing blood vessel growth.

A specific gene change plus an additional mutation in the same gene cause hereditary trichilemmal cysts.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

Specific cross-linkages help make hair proteins stable and strong.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Enzymatic phosphorylation of hair keratin improves the effectiveness of hair products with cationic ingredients.

PTeCA is a reliable marker for detecting oxidative hair treatments.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

More research is needed to understand chemotherapy-induced hair loss and its phases.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

The combination therapy was effective and well-tolerated, especially in young patients.

Inhibiting certain brain neurons may reduce pain and anxiety in trigeminal neuralgia.

NGF-modified hair follicle stem cells may help treat Alzheimer's by improving brain function and reducing harmful proteins.